Karen L. Smith - Director at Aurinia Pharmaceuticals Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
AUPH on Nasdaq
All Insider Reports
All Insider Reports

Karen L. Smith - trading volume in the past year for Aurinia Pharmaceuticals Inc.

Holdings reported by Karen L. Smith for Aurinia Pharmaceuticals Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 12.7K $107K $8.43 Nov 11, 2024 Direct
Restricted Stock Units 0 Nov 8, 2024 Direct Common Stock

Transactions reported by Karen L. Smith for Aurinia Pharmaceuticals Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.